99mTc-MDP abdominal scintigraphy in a paediatric case of GI protein loss - A viable and simple alternate to HSA imaging

Document Type : Case Report


Department of Nuclear Medicine & PET/CT, Amrita Institute of Medical Sciences, Cochin, Kerala, India


A nine-month old male child presented with low-grade fever, loose stools and facial puffiness. Clinically patient was otherwise normal except for a firm liver on palpation. The laboratory tests revealed hypoproteinemia (both albumin and globulin) and iron deficiency anemia. Differential diagnosis considered were: 1. Nephrotic syndrome, 2. Cystic fibrosis (in view of recurrent diarrhea and respiratory complaints) 3. Chronic liver disease, in view of firm palpable liver 4. Lastly protein losing enteropathy (PLE). As biochemically patient revealed no positive results, PLE was suspected. For confirmation  99mTc-Methylene diphosponate (MDP) scintigraphy was found to be useful in the setting of non availability of 99mTc-HSA. MDP scan revealed abnormal minimal extravasation of tracer from bowel loops in right lower abdominal quadrant suggesting a diagnosis of PLE. According to the American Gastroenterological Association (AGA) in patients with iron-deficiency anemia who do have GI symptoms, the prevalence of celiac disease is higher and ranges from 10% to 15% which may be a plausible explanation in our patient. The diagnosis of PLE is most commonly based on the determination of fecal alpha-1 antitrypsin clearance. However the localization of gastrointestinal protein (GI) protein loss is possible by scintgraphic techniques alone, as was done in our case using 99mTc-MDP instead of conventionally used 99mTc-HSA.


Main Subjects

Halaby H, Bakheet SM, Shabib S, Powe JE, Al Mehaidib A, Nazer H. 99mTc-human serum albumin scans in children with protein-losing enteropathy. J Nucl Med. 2000 Feb;41(2):215-9.
Divgi CR, Lisann NM, Yeh SD, Benua RS. Technetium-99m albumin scintigraphy in the diagnosis of protein-losing enteropathy. J Nucl Med. 1986 Nov;27(11):1710-2.
Florent C, Vidon N, Flourié B, Carmantrand A, Zerbani A, Maurel M, Bernier JJ. Gastric clearance of alpha-1-antitrypsin under cimetidine perfusion. New test to detect protein-losing gastropathy? Dig Dis Sci. 1986 Jan;31(1):12-5.
Freeman T, Gordon AH. Measurement of albumin leak into the gastrointestinal tract using I-131 albumin and ion exchange resins by mouth. Gut. 1964 Apr;5:155-7.
Martinez-Sanchis B, Cortés-Vizcaíno V, Frontado-Morales L, Sopena-Novales P. Intestinal uptake of (99m)Tc-MDP: a case report of protein-losing enteropathy correlated with pathology findings from autopsy. Ann Nucl Med. 2011 Feb;25(2):139-41.
Seok JW, Kim S, Lee SH, Kim IJ, Kim YK. Protein-losing enteropathy detected on Tc-99m HSA and Tc-99m MDP scintigraphy. Clin Nucl Med. 2002 Jun;27(6):431-3.
Uzuner O, Ziessman HA. Protein-losing enteropathy detected by Tc-99m-MDP abdominal scintigraphy. Pediatr Radiol. 2008 Oct;38(10):1122-4.
Ergün EL, Kiratli PO, Günay EC, Erbaş B. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature. Nucl Med Commun. 2006 Nov;27(11):877-85.
Meristoudis G, Birbilis C, Ilias I, Tsaroucha A, Batsakis C, Christakopoulou J. Intestinal accumulation of 99mTc-MDP in a patient with protein-losing enteropathy. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):224.
Waldmann TA. Gastrointestinal protein loss demonstrated by Cr-51-labelled albumin. Lancet. 1961 Jul 15;2(7194):121-3.
Plantin LO, Strandberg O. Gastrointestinal protein loss in rheumatoid arthritis, studied with 51Cr-chromic chloride and 125I albumin. Scand J Rheumatol. 1974;3(4):169-73.
Bhatnagar A, Mishra P, Singh AK, Taneja V, Chauhan UP, Sawroop K. Scintiscan demonstration of localized bowel loop inflammation. Comparison of Tc-99m dextran, Tc-99m citrate, and Tc-99m human immunoglobulin G. Clin Nucl Med. 1996 Sep;21(9):685-8.
Bhatnagar A, Singh AK, Lahoti D, Singh T, Khanna CM. Technetium-99m dextran: a promising new protein-losing enteropathy imaging agent. Eur J Nucl Med. 1996 May;23(5):575-8.
Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996 Jan;37(1):185-92. [Erratum: J Nucl Med 1996 Jun;37(6):1064-7.]
AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology. 2006 Dec;131(6):1977-80.